PEDIATRICS Vol. 123 No. 4 April 2009, pp. 1132-1141 (doi:10.1542/peds.2008-0526)
ARTICLE |
Cytokines Associated With Bronchopulmonary Dysplasia or Death in Extremely Low Birth Weight Infants
a Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama
b Department of Pediatrics, University of Rochester Medical Center, Rochester, New York
c Statistics and Epidemiology Unit RTI International, Research Triangle Park, North Carolina
d National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
e NANEA Department of Epidemiology Institute of Public Health, University of Aarhus, Aarhus, Denmark; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia
f Neonatal Research Network, Pregnancy and Perinatology Branch, Center for Developmental Biology and Perinatal Medicine, Bethesda, Maryland
OBJECTIVE. The goal was to develop multivariate logistic regression models for the outcome of bronchopulmonary dysplasia and/or death at postmenstrual age of 36 weeks by using clinical and cytokine data from the first 28 days.
METHODS. For 1067 extremely low birth weight infants in the Neonatal Research Network of the National Institute of Child Health and Human Development, levels of 25 cytokines were measured in blood collected within 4 hours after birth and on days 3, 7, 14, and 21. Stepwise regression analyses using peak levels of the 25 cytokines and 15 clinical variables identified variables associated with bronchopulmonary dysplasia/death. Multivariate logistic regression analysis was performed for bronchopulmonary dysplasia/death by using variables selected through stepwise regression. Similar analyses were performed by using average cytokine values from days 0 to 21, days 0 to 3, and days 14 to 21.
RESULTS. Of 1062 infants with available data, 606 infants developed bronchopulmonary dysplasia or died. On the basis of results from all models combined, bronchopulmonary dysplasia/death was associated with higher concentrations of interleukin 1β, 6, 8, and 10 and interferon
and lower concentrations of interleukin 17, regulated on activation, normal T cell expressed and secreted, and tumor necrosis factor β. Compared with models with only clinical variables, the addition of cytokine data improved predictive ability by a statistically significant but clinically modest magnitude.
CONCLUSIONS. The overall cytokine pattern suggests that bronchopulmonary dysplasia/death may be associated with impairment in the transition from the innate immune response mediated by neutrophils to the adaptive immune response mediated by T lymphocytes.
Key Words: logistic models infant premature predictive value of tests
Abbreviations: BPD—bronchopulmonary dysplasia ELBW—extremely low birth weight IL—interleukin IFN—interferon RANTES—regulated on activation, normal T cell expressed and secreted TNF—tumor necrosis factor IMV—intermittent mandatory ventilation CRP—C-reactive protein BDNF—brain-derived neurotrophic factor MCP—monocyte chemoattractant protein Th—T helper TGF—transforming growth factor TREM1—triggering receptor expressed on myeloid cells 1
Accepted Aug 21, 2008.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
S. H. Abman and M. A. Matthay Mesenchymal Stem Cells for the Prevention of Bronchopulmonary Dysplasia: Delivering the Secretome Am. J. Respir. Crit. Care Med., December 1, 2009; 180(11): 1039 - 1041. [Full Text] [PDF] |
||||
![]() |
M. Aslam, R. Baveja, O. D. Liang, A. Fernandez-Gonzalez, C. Lee, S. A. Mitsialis, and S. Kourembanas Bone Marrow Stromal Cells Attenuate Lung Injury in a Murine Model of Neonatal Chronic Lung Disease Am. J. Respir. Crit. Care Med., December 1, 2009; 180(11): 1122 - 1130. [Abstract] [Full Text] [PDF] |
||||





